Evommune, Inc. (EVMN) Current Reports & Earnings Releases
Upcoming
- 2026-12-10 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-30 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-29 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-02 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-07 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2026-04-13 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-05 | 8-K | Results of Operations | SEC |
| 2026-02-13 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-10 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-12-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-07 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.